Multi-arm Trial of Inflammatory Signal Inhibitors (MATIS) for hospitalised patients with mild or moderate COVID-19 pneumonia: a structured summary of a study protocol for a randomised controlled trial

Overview of attention for article published in Trials, April 2021

Altmetric Badge

Mentioned by

So far, Altmetric has seen 20 X posts from 18 X users, with an upper bound of 26,666 followers.

RT @MATISTrial: MATIS trial protocol published as a structured summary out now here: https://t.co/VxCuORpp92 @DrAWhittington @VR_Cornelius…

RT @TYoungstein: Fostamatinib: Ruxolitinib: SoC in COVID-19 patients from admission. @imperialcollege @ImperialNHS study now multi-site…

RT @MATISTrial: MATIS trial protocol published as a structured summary out now here: https://t.co/VxCuORpp92 @DrAWhittington @VR_Cornelius…

RT @TYoungstein: Fostamatinib: Ruxolitinib: SoC in COVID-19 patients from admission. @imperialcollege @ImperialNHS study now multi-site…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 16 additional X posts.